Načítá se...
Effects of empagliflozin treatment on glycerol-derived hepatic gluconeogenesis in obese adults: a randomized clinical trial
OBJECTIVE: To determine the effects of empagliflozin on glycerol-derived hepatic gluconeogenesis in obese adults without type 2 diabetes mellitus (T2DM) using oral (13)C-labeled glycerol. METHODS: We performed a randomized, double-blind, placebo-controlled trial in participants with MRI assessment o...
Uloženo v:
| Vydáno v: | Obesity (Silver Spring) |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316140/ https://ncbi.nlm.nih.gov/pubmed/32568464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22854 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|